The positions in the table below reflect the Merck Sharp and Dohme B.V. (MSD BV Haarlem)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each ...

Merck Sharp & Dohme LLC has identified compounds acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1) and/or 2 (HCN2) blockers reported to be useful for the ...

A recent Merck Sharp & Dohme LLC patent details new substituted isoquinoline derivatives acting as tyrosine-protein phosphatase non-receptor type 1 (PTPN1; PTP-1B) and/or PTPN2 (TCPTP) inhibitors ...

Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.

Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. The articles listed below published by authors from Merck Sharp and Dohme B.V. (MSD BV ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Plunging sales of Merck’s blockbuster HPV vaccine in China have caused a sharp fall in the US pharma group’s ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cytomegalovirus (CMV) Infection pipeline constitutes 15+ key companies continuously working towards ...